Immunomic is pleased to share that CEO Dr. Bill Hearl served as a panelist during The Washington Post’s Chasing Cancer Summit in Washington, D.C. on Tuesday, Dec. 7th. The event was focused on modern healthcare cost drivers and solutions. The Chasing Cancer series was created and hosted by The Washington Post to bring together scientists, healthcare innovators, patients and policymakers to discuss advances in cancer detection and treatment. Dr. Bill Hearl shared his thoughts on value in health care and how companies are balancing the costs of developing and delivering innovative technologies with the need for affordable care in the treatment of cancer. Other participants in the Dec. 6th event included: • Drew Pardoll, Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics; Johns Hopkins University • Fran Drescher, Actress; Founder, Cancer Schmancer Foundation • Taboo, Rapper, The Black Eyed Peas; Global Ambassador, American Cancer Society • Rep. Marsha Blackburn • Rep. Debbie Wasserman Schultz.

Further coverage may be found in The Washington Post and our media advisory.